Abstract

BackgroundLymph node metastasis (LNM) commonly occurs in gastric cancer (GC) and is tightly associated with poor prognosis. Exosome-mediated lymphangiogenesis has been considered an important driver of LNM. Whether exosomes directly transmit the LNM phenotype between GC cells and its mechanisms remain elusive.MethodsA highly lymphatic metastatic GC cell line (HGC-27-L) was established by serial passage of parental HGC-27 cells in BALB/c nude mice. The capacities of migration, invasion and LNM; fatty acid oxidation (FAO) levels; and the role of exosome-transferred LNM phenotype were compared among HGC-27-L, HGC-27 and primary GC cell line AGS. Exosomes derived from GC cells and sera were separately isolated using ultracentrifugation and ExoQuick exosome precipitation solution, and were characterized by transmission electron microscopy, Nanosight and western blotting. Transwell assay and LNM models were conducted to evaluate the capacities of migration, invasion and LNM of GC cells in vitro and in vivo. β-oxidation rate and CPT1 activity were measured to assess FAO. CPT1A inhibitor etomoxir was used to determine the role of FAO. Label-free LC-MS/MS proteome analysis screened the differential protein profiling between HGC-27-exosomes and AGS-exosomes. Small interference RNAs and YAP inhibitor verteporfin were used to elucidate the role and mechanism of exosomal CD44. TCGA data analysis, immunochemistry staining and ELISA were performed to analyze the expression correlation and clinical significance of CD44/YAP/CPT1A.ResultsFAO was increased in lymphatic metastatic GC cells and indispensable for sustaining LNM capacity. Lymphatic metastatic GC cell-exosomes conferred LNM capacity on primary GC cells in an FAO-dependent way. Mechanistically, CD44 was identified to be enriched in HGC-27-exosomes and was a critical cargo protein regulating exosome-mediated transmission, possibly by modulating the RhoA/YAP/Prox1/CPT1A signaling axis. Abnormal expression of CD44/YAP/CPT1A in GC tissues was correlated with each other and associated with LNM status, stages, invasion and poor survival. Serum exosomal CD44 concentration was positively correlated with tumor burden in lymph nodes.ConclusionsWe uncovered a novel mechanism: exosomal CD44 transmits LNM capacity between GC cells via YAP-CPT1A-mediated FAO reprogramming from the perspective of exosomes-transferred LNM phenotype. This provides potential therapeutic targets and a non-invasive biomarker for GC patients with LNM.

Highlights

  • Lymph node metastasis (LNM) frequently occurs whenever gastric cancer (GC) patients are diagnosed at an early or advanced stage; it is recognized as an important indicator of poor prognosis [1]

  • We evaluated the role of exosome-mediated LNM phenotype transmission from lymphatic metastatic GC cells to primary GC cells through fatty acid oxidation (FAO), identified key proteins mediating exosome regulation and elucidated its downstream signaling pathway

  • Even though incubation with HGC-27-exosome, AGS cells formed reduced volume, weight and positive pancytokeratin-AE1/AE3 expression area of popliteal lymph node (LN) in VP treatment groups relative to the control groups (Figures 5M–O). These results suggest that exosomal CD44 might regulate the ras homolog family member A (RhoA)/Yesassociated protein (YAP)/Prospero Homeobox 1 (Prox1)/carnitine palmitoyltransferase 1a (CPT1A) signaling axis to promote FAO in recipient cells and confer LNM capacity

Read more

Summary

Introduction

Lymph node metastasis (LNM) frequently occurs whenever gastric cancer (GC) patients are diagnosed at an early or advanced stage; it is recognized as an important indicator of poor prognosis [1]. Lymphadenectomy is commonly used to prevent further LNM, but it has been reported that extended lymphadenectomy might result in recurrence and cancer-related death. Adjuvant treatments reduce the recurrence and metastasis of GC to a certain extent, their side effects are inevitable. Effective therapeutic molecular targets for LNM are still lacking. Elucidating the underlying molecular mechanism of LNM during GC progression is important. Lymph node metastasis (LNM) commonly occurs in gastric cancer (GC) and is tightly associated with poor prognosis. Exosome-mediated lymphangiogenesis has been considered an important driver of LNM. Whether exosomes directly transmit the LNM phenotype between GC cells and its mechanisms remain elusive

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.